What changed for 2026: Medicare’s temporary add‑on for certain non‑opioid pain treatments

Beginning January 1, 2026, Medicare is implementing a time‑limited additional payment under the hospital outpatient and ambulatory surgery center payment systems for certain non‑opioid pain treatments used around outpatient procedures. This Section 4135 policy runs through December 31, 2027 and follows a quarterly implementation process that updates which treatments are eligible for the temporary add‑on. The payment is made to the facility, not to individual clinicians, and is intended to support availability of specific non‑opioid options during outpatient care. Patients and families can expect clinics and surgery centers to confirm, quarter by quarter, what is eligible and stocked on site. These are payment and coverage details—not treatment recommendations—and clinical choices remain individualized. [6 (opens in a new tab), 3 (opens in a new tab), 8 (opens in a new tab)]

How the policy can influence conversations before outpatient spine or knee care

Because the add‑on is paid to facilities under the outpatient hospital and ambulatory surgery center payment systems, it may affect which non‑opioid options are routinely available during outpatient spine or knee procedures at a given site. A facility that receives an add‑on for an eligible non‑opioid option may be more able to stock or operationalize it, but this is not guaranteed, and choices still depend on clinical fit, safety, and local protocols. The add‑on is temporary, eligibility is updated on a quarterly cycle, and not all drugs, biologicals, or techniques will qualify. Your care team will still individualize perioperative pain control based on your condition, goals, and risk factors. [3 (opens in a new tab), 6 (opens in a new tab), 8 (opens in a new tab)]

Many perioperative plans use a multimodal approach—combining non‑opioid strategies such as local anesthetics and selected non‑opioid medications when appropriate—to reduce reliance on opioids while aiming to maintain function and safety. Multimodal plans are tailored, may change over time, and should weigh benefits and risks for the individual. Education about options, expected course, and monitoring is central. Any medication changes should be coordinated with the prescribing clinician; do not make changes on your own. [2 (opens in a new tab)]

Examples you may hear about during planning (without implying coverage or fit)

Discussions before outpatient spine or knee care may include local anesthetic infiltration at the incision or joint and facility‑administered non‑opioid medications that can be part of a multimodal strategy when appropriate. CMS maintains resources explaining how certain non‑opioid drugs or biologicals that function as supplies to surgical services may be eligible for separate payment in addition to policy‑specific add‑on pathways for 2026–2027. Whether a particular drug, combination product, or technique is eligible can change as CMS updates its lists and instructions. Examples previously addressed by CMS include selected local anesthetic formulations; current eligibility is determined by quarterly and program guidance. Availability at your site is not assured and depends on facility decisions and clinical judgment. [1 (opens in a new tab), 4 (opens in a new tab), 6 (opens in a new tab), 7 (opens in a new tab)]

Questions to ask before a planned outpatient spine or knee procedure

  • Which non‑opioid pain options are available at this facility for my type of outpatient procedure, and which team members will discuss the plan with me?
  • Are any of the non‑opioid options you use currently on Medicare’s eligible list for the 2026–2027 temporary add‑on, and how do quarterly updates affect what is stocked here? [6 (opens in a new tab)]
  • If a non‑opioid option is eligible for a facility add‑on or separate payment, does that change anything I should expect about counseling, consent, or billing in this setting? [3 (opens in a new tab), 4 (opens in a new tab), 8 (opens in a new tab)]
  • What does a multimodal plan look like for a case like mine, and how will function and mobility goals be incorporated into the perioperative plan? [2 (opens in a new tab)]
  • How will potential risks be screened for when considering non‑opioid medications or anesthetic techniques? [2 (opens in a new tab)]
  • What should I track at home in the first few days—such as walking distance, sleep, ability to perform basics safely—and how should I report concerns or unexpected effects? [2 (opens in a new tab)]
  • If opioids are considered, what education, monitoring, and duration planning will be used, and how will the team coordinate with my existing prescribers? I will not make medication changes without my prescribing clinician. [2 (opens in a new tab)]
  • How will my current medication list, allergies, anticoagulants, and supplements be reviewed for interactions with any perioperative non‑opioid options? [2 (opens in a new tab)]
  • Who should I contact after hours if pain control is not tolerable or if side effects occur, and what symptoms would require immediate emergency evaluation rather than a routine call? [2 (opens in a new tab), 5 (opens in a new tab), 10 (opens in a new tab)]
  • Does facility participation in the Medicare outpatient payment systems (hospital outpatient department or ASC) affect which options are feasible here? [3 (opens in a new tab), 8 (opens in a new tab)]

What to bring and how to prepare for a pain‑clinic discussion

Bring an up‑to‑date medication and supplement list with doses and timing; any prior anesthesia or injection records you have; a brief history of reactions to pain medicines or numbing medicines; and your top function goals for the first week after surgery, such as safely getting in and out of a chair, walking to the bathroom, or navigating stairs. A simple daily log of pain fluctuations, sleep quality, and movement milestones can help your team calibrate expectations and safety monitoring. If you use devices like a cane, brace, or CPAP, note how they factor into your immediate postoperative plan. Any medication adjustments should be clinician‑led and coordinated with the prescribing clinician. [2 (opens in a new tab)]

Safety check: symptoms that require emergency evaluation

For back or leg symptoms, call emergency services or go to the nearest emergency department now for new bladder or bowel dysfunction — seek immediate emergency care or call 911, new saddle‑area numbness, or rapidly progressive leg weakness. For neck symptoms, call emergency services or go to the nearest emergency department now for new gait imbalance, new hand clumsiness, or rapidly worsening limb weakness. Imaging decisions for lumbar issues use different timing considerations than for cervical problems; your team will address this separately during a visit. [5 (opens in a new tab), 10 (opens in a new tab)]

Limitations and uncertainties to keep in mind

The 2026 non‑opioid add‑on is temporary and currently defined for services furnished from January 1, 2026 through December 31, 2027, subject to quarterly implementation steps and updates from CMS. Inclusion on an eligible list does not obligate a facility to use a particular product or technique, and payment policy does not determine medical appropriateness. CMS also maintains a separate pathway for certain non‑opioid drugs or biologicals that function as surgical supplies to receive separate payment during 2025–2027; that pathway is distinct from the 2026–2027 add‑on. The interplay of these policies can be complex, and the specifics may change with future quarterly or annual rulemaking. Facilities and clinicians will continue to make individualized decisions based on safety, evidence, workflow, and patient goals. [6 (opens in a new tab), 4 (opens in a new tab), 3 (opens in a new tab)]

How CMS Pain Management & Rehab fits into your plan

At CMS Pain Management & Rehab in Sandy Springs, our role around outpatient spine or knee procedures is to help you prepare, understand options, and plan for function and safety across the perioperative period. We can coordinate with your surgical team and the facility to clarify which non‑opioid options are feasible under current Medicare outpatient payment policies, explain what multimodal plans may involve, and align monitoring and communication. Education about risks, benefits, and uncertainty is central, and any medication changes are clinician‑led and coordinated with your prescribing clinicians. Facility participation and payment rules come from the hospital outpatient and ambulatory surgery center systems; your team can help interpret what applies in your setting. [3 (opens in a new tab), 8 (opens in a new tab), 2 (opens in a new tab), 9]

FAQs

Does the 2026 Medicare add‑on for non‑opioid treatments mean I will definitely avoid opioids after my procedure?

Not necessarily. The add‑on is a temporary facility payment policy for specific non‑opioid treatments; it does not dictate clinical decisions. Perioperative pain plans remain individualized, and opioids may be used when benefits are judged to outweigh risks. Current guidelines emphasize education, multimodal strategies, and careful risk–benefit assessment when considering opioids for acute pain. [6 (opens in a new tab), 2 (opens in a new tab)]

Will this policy lower my out‑of‑pocket costs for pain control after outpatient surgery?

The add‑on is paid to facilities under the outpatient hospital and ASC payment systems. It may affect what a site can stock or offer, but it is not a guarantee of use and does not set your coinsurance by itself. Out‑of‑pocket amounts depend on your Medicare coverage, the setting (hospital outpatient department versus ASC), and billing details for the services you receive. Your facility can explain how current payment rules apply to your case. [3 (opens in a new tab), 8 (opens in a new tab)]

Are products like liposomal bupivacaine or bupivacaine–meloxicam included under Medicare’s non‑opioid policies?

CMS resources explain that certain non‑opioid drugs or biologicals functioning as supplies to surgical services can be eligible for separate payment, and additional temporary add‑on eligibility applies in 2026–2027 for specific non‑opioid pain treatments. Some local anesthetic formulations have been addressed in prior CMS decisions. Current eligibility is determined by quarterly and program guidance; your facility can confirm what applies this quarter. [1 (opens in a new tab), 4 (opens in a new tab), 6 (opens in a new tab), 7 (opens in a new tab)]

How should I prepare medication‑wise for a pre‑op pain‑clinic visit?

Bring a complete medication and supplement list, note any prior reactions to pain or numbing medicines, and clarify who prescribes each medicine you use so the team can coordinate. Ask how multimodal options may fit your case, what to track at home, and how to reach the team after hours. Do not make medication changes without the prescribing clinician. [2 (opens in a new tab)]

Sources

When to Talk With a Clinician

For non-emergency questions, contact CMS Pain Management & Rehab to discuss your symptoms and care options with a qualified clinician. For emergency warning signs, call 911 or seek emergency care now rather than contacting the clinic.

Medical disclaimer: This article is for general education and is not a diagnosis or a substitute for individualized medical advice. Treatment options, risks, and eligibility vary; consult a qualified healthcare professional.

This article provides general information and is not an individual diagnosis or treatment recommendation. Ask your clinician how the information relates to your health. The accompanying stock photograph is illustrative.

Originally published Oct 5, 2026. Last updated Oct 5, 2026.